A phase I trial of mifepristone (M), carboplatin (C), and gemcitabine (G) in advanced breast and ovarian cancer
Stringer, Erica Michelle, Saha, Poornima, Swoboda, April, Kocherginsky, Masha, Baker, Gabrielle, Olberkyte, Simona, Owusu, Nana, Dyer, Brittany, Olalde, Lauren, Olszewski, Elizabeth, Hahn, Olwen Mary, Hoffman, Philip C., Phillips, Brooke Elizabeth, Suh, Grace K., Conzen, Suzanne D., Fleming, Gini F., Nanda, Rita
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
The role of the glucocorticoid receptor (GR) in inhibiting chemotherapy-induced apoptosis in high-grade serous ovarian carcinoma (HGS-OvCa)
Stringer, Erica Michelle, Skor, Maxwell N., Fleming, Gini F., Conzen, Suzanne D.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Phase I/II study of stereotactic radiosurgery with concurrent olaparib followed by adjuvant durvalumab and physician’s choice systemic therapy in patients with breast cancer brain metastases
Shen, Colette, Abdou, Yara, Chen, Linda, Tan, Xianming, Gupta, Gaorav P., Lynce, Filipa, Lobbous, Mina, Stringer-Reasor, Erica Michelle, Anders, Carey K.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer
Chen, Nan, Saha, Poornima, Rampurwala, Murtuza M., Kamaraju, Sailaja, Hahn, Olwen Mary, Howard, Frederick Matthew, Fleming, Gini F., Matossian, Margarite, Freeman, Jincong Q., Karrison, Theodore, Conzen, Suzanne D., Nanda, Rita, Stringer-Reasor, Erica Michelle
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Cardiac dysfunction (CD) among breast cancer survivors (BCS): Role of cardiotoxic therapy and cardiovascular risk factors
Bostany, Geoffrey S., Chen, Yanjun, Francisco, Liton, Dai, Chen, Meng, Qingrui, Sparks, Jessica R, Sessions, Min, Nabell, Lisle, Stringer-Reasor, Erica Michelle, Khoury, Katia, Lenneman, Carrie, Keene, Kimberly Sue, Landier, Wendy, Bhatia, Smita
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008
Braunstein, Lior Zvi, Mitchell, Melissa, Bandos, Hanna, Sikov, William M., Khan, Atif J., Chen, Peter Y., Ganz, Patricia A., Jagsi, Reshma, White, Julia R., Cecchini, Reena S., Kang, Hyejoo, Puhalla, Shannon L., Bolton, Kelly L., Connolly, Eileen, Stringer-Reasor, Erica Michelle, Gergelis, Kimberly, Julian, Thomas B., Mamounas, Eleftherios P., Wolmark, Norman
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy: ECOG-ACRIN EA1211/DIRECT trial
Hennessy, Maeve, Gatsonis, Constantine, Jacene, Heather, Connolly, Roisin M., Burnette, Brian Leslie, Stringer-Reasor, Erica Michelle, Romanoff, Justin, Taurone, Alexander, O'Sullivan, Ciara Catherine, Le-Petross, Huong T., Lawhn Heath, Courtney, Stearns, Vered, Fowler, Amy M., Tang, Shou-Ching, Sepulveda, Karla, DeMichele, Angela, Mankoff, David A., Wolff, Antonio C.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Correlation of TILs indices generated by visual review and digital computational algorithm with outcomes from preoperative chemotherapy for TNBC in TBCRC 030
Nader Marta, Guilherme, Chu, Xiangying, Mukhopadhyay, Satabhisa, Abramson, Vandana G, Brufsky, Adam, Stringer-Reasor, Erica Michelle, Dent, Susan Faye, Traina, Tiffany A., Carey, Lisa A., Rimawi, Mothaffar F., Specht, Jennifer M., Miller, Kathy, Santa-Maria, Cesar Augusto, Dasgupta, Tathagata, Binboğa Kurt, Busem, Tayob, Nabihah, Krop, Ian E., Tung, Nadine M., Schnitt, Stuart J., Mayer, Erica L.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Incidence and time to onset of immunotherapy-related adrenal insufficiency in the I-SPY2 trial
Nanda, Rita, Cohen, Ronald, Quandt, Zoe, Basu, Amrita B, Yau, Christina, Chien, Amy Jo, Pusztai, Lajos, Han, Hyo S., Stringer-Reasor, Erica Michelle, Isaacs, Claudine, Hershman, Dawn L., Shatsky, Rebecca Arielle, Perlmutter, Jane, Yee, Douglas, DeMichele, Angela, van 't Veer, Laura, Hylton, Nola, Esserman, Laura, Rugo, Hope S.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL
Yeung, Kay T, Kalinsky, Kevin, Yau, Christina, Chien, Amy Jo, Boughey, Judy Caroline, Stringer-Reasor, Erica Michelle, Falkson, Carla Isadora, Albain, Kathy S., Mayer, Ingrid A., Trivedi, Meghna S., Nanda, Rita, Douglas, Emily H., Omene, Coral Oghenerukevwe, Rugo, Hope S., Isaacs, Claudine, Parker, Beverly, DeMichele, Angela, Yee, Douglas, Esserman, Laura
Published in Journal of clinical oncology (10.06.2023)
Published in Journal of clinical oncology (10.06.2023)
Get full text
Journal Article
Oral paclitaxel and dostarlimab with or without trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant ISPY 2 TRIAL
Shatsky, Rebecca Arielle, Thomas, Alexandra, Yau, Christina, Chien, Amy Jo, Falkson, Carla Isadora, Stringer-Reasor, Erica Michelle, Omene, Coral Oghenerukevwe, Trivedi, Meghna S., Boughey, Judy Caroline, Sanford, Amy, Arora, Mili, Sanft, Tara B., Nanda, Rita, Isaacs, Claudine, Brown, Thelma, Hylton, Nola, DeMichele, Angela, Yee, Douglas, Esserman, Laura
Published in Journal of clinical oncology (10.06.2023)
Published in Journal of clinical oncology (10.06.2023)
Get full text
Journal Article
Biomarkers predicting response to 5 immunotherapy arms in the neoadjuvant I-SPY2 trial for early-stage breast cancer (BC): Evaluation of immune subtyping in the response predictive subtypes (RPS)
Wolf, Denise M., Yau, Christina, Campbell, Michael J., Glas, Annuska M., Mittempergher, Lorenza, Kuilman, Midas M., Barcaru, Andrei, Brown Swigart, Lamorna, Nanda, Rita, Chien, Amy Jo, Pusztai, Lajos, Stringer-Reasor, Erica Michelle, Shatsky, Rebecca Arielle, Isaacs, Claudine, Perlmutter, Jane, DeMichele, Angela, Yee, Douglas, Esserman, Laura, van 't Veer, Laura
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Financial toxicity among breast cancer survivors with health insurance
Landier, Wendy, Dai, Chen, Sparks, Jessica, Anthony, Katie Rose, Barrett, Jeffrey S., Hageman, Lindsey, Francisco, Liton, Rocque, Gabrielle Betty, Stringer-Reasor, Erica Michelle, Nabell, Lisle, Bhatia, Smita
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Trial in progress: A phase 1b/2 study of the PARP inhibitor niraparib in combination with trastuzumab in patients with metastatic HER2+ breast cancer (TBCRC 050)
Stringer-Reasor, Erica Michelle, Li, Yufeng, Witherspoon, Felicia, Specht, Jennifer M., Anampa Mesias, Jesus Del Santo, Nanda, Rita, Dees, Elizabeth Claire, Wolff, Antonio C., Krop, Ian E., Lin, Nancy U, Rimawi, Mothaffar F., Yang, Eddy Shih-Hsin
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
An open label, pilot study of veliparib (ABT-888) and lapatinib in patients with metastatic, triple negative (ER, PR, and HER-2 negative) breast cancer
Stringer-Reasor, Erica Michelle, Yang, Eddy Shih-Hsin, May, Jori E., Caterinicchia, Valerie, Li, Yufeng, Forero-Torres, Andres
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Phase 1b/2 study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of triple-negative breast cancer (SGNLVA-002, trial in progress)
Meisel, Jane Lowe, Pluard, Timothy J., Vinayak, Shaveta, Stringer-Reasor, Erica Michelle, Brown-Glaberman, Ursa, Dillon, Patrick Michael, Basho, Reva K, Varadarajan, Ramya, O'Shaughnessy, Joyce, Han, Hyo S., Sinha, Rajni, Fox, Jenny R., Villanueva, Rafael, Chen, Lin Chi, Wu, Sheng, Li, Hong, Tran, Sinhan, Manso, Luis
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Biomarker analysis from a phase I study using gedatolisib+palbociclib+hormone therapy in ER+/HER2- metastatic breast cancer (mBC)
Wesolowski, Robert, Pathan, Nuzhat, Zhu, Zhou, Stringer-Reasor, Erica Michelle, Han, Hyo S., Dees, Elizabeth Claire, Bardia, Aditya, Layman, Rachel M., Weise, Amy, Kabos, Peter, Lu, Janice M., Kern, Kenneth Alan, Pierce, Kristen J., Rugo, Hope S.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Pharmacokinetic (PK) analyses in CSF and plasma from TBCRC049, an ongoing trial to assess the safety and efficacy of the combination of tucatinib, trastuzumab and capecitabine for the treatment of leptomeningeal metastasis (LM) in HER2 positive breast cancer
Stringer-Reasor, Erica Michelle, O'Brien, Barbara Jane, Topletz-Erickson, Ariel, White, Jason B, Lobbous, Mina, Riley, Kristen, Childress, Jennifer, LaMaster, Kim, Melisko, Michelle E., Morikawa, Aki, De Groot, John Frederick, Krop, Ian E., Valero, Vicente, Rimawi, Mothaffar F., Wolff, Antonio C., Tripathy, Debu, Lin, Nancy U, Murthy, Rashmi Krishna
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Evaluation of intra-tumoral (IT) SD-101 and pembrolizumab (Pb) in combination with paclitaxel (P) followed by AC in high-risk HER2-negative (HER2-) stage II/III breast cancer: Results from the I-SPY 2 trial
Chien, Amy Jo, Soliman, Hatem Hussein, Ewing, Cheryl Ann, Boughey, Judy Caroline, Campbell, Michael J., Rugo, Hope S., Wallace, Anne M., Albain, Kathy S., Stringer-Reasor, Erica Michelle, Church, An L, Kalinsky, Kevin, Elias, Anthony D., Mitri, Zahi Ibrahim, Clark, Amy Sanders, Nanda, Rita, Thomas, Alexandra, Yau, Christina, Berry, Donald A, Esserman, Laura
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Clinical pharmacology assessment of PF-06647020 (PF-7020), an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in adult patients (pts) with advanced solid tumors
Xuan, Dawei, Xin, Xiaohua (Robert), Gibson, Brenda, Joh, Tenshang, Yin, Hequn, Garzone, Pamela D., Sachdev, Jasgit C., Maitland, Michael L., Sharma, Manish, Moreno, Victor, Calvo, Emiliano, Kummar, Shivaani, Stringer-Reasor, Erica Michelle, Lakhani, Nehal J., Tolcher, Anthony W., Beaupre, Darrin M.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article